MoU to strengthen cancer care treatment pathways and capabilities of healthcare professionals in DSCI
Roche Pharma India and Delhi State Cancer Institute (DSCI) have inked a MoU to strengthen the cancer care capabilities at DSCI and enable delivery of quality and comprehensive cancer care treatment for patients who get treated in the DSCI network. The partnership will bolster and close the current gaps in cancer prevention and management across DSCI, enabling it to become a leader in Oncology care.
Satyendar Jain, Health Minister of Delhi said, “Owing to the multi-disciplinary nature of care required for cancer management and the growing need for cancer awareness, the government has recognised the need to curb this disease from turning into an epidemic. Through this partnership, we look forward to improving patient treatment outcomes, and knowledge and skills of people involved in delivering cancer care in the DSCI network. PPP models like this enable us to expand our service delivery network by actively encouraging learning, participations and integration with other Delhi government hospitals.”
The partnership between Roche and DSCI, initially for a period of 3 years, will focus on the following objectives:
- Improve access to timely identification and innovative advanced treatment therapies for various cancers through capacity building and mentorship programs for oncologists at DSCI (East and West) in partnership national and international experts in oncology.
- Establish an educational Virtual Tumor Boards (VTBs) to standardize the management of complex oncology cases based on recommendations from NCCN, ESMO, ASCO guidelines. These VBTs will be held twice a month where complex oncology cases being treated at DSCI will be discussed with leading medical oncologists. This initiative will also enhance the expertise of HCPs in DSCI in managing difficult oncology cases.
- Training of Medical Oncology Paramedic staff to upgrade their overall skillset and ensure better care outcomes
- Demonstrate and Develop Cancer Care referral pathway across the Delhi government hospitals
- Enhance technical knowledge through ongoing medical education for Oncologists and other HCPs involved in providing cancer treatment and care at DSCI (East and West) and across Delhi government hospitals by providing access to research articles, pivotal clinical trial details, oncology updates, latest NCCN guidelines etc.
Commenting on this partnership, V. Simpson Emmanuel, Managing Director & CEO, Roche Pharma said, “At Roche, we are driven by the passion and science to improve patient lives, especially in the area of Oncology. Through its various access initiatives with healthcare ecosystems, Roche is committed to make a positive, meaningful difference in the lives of patients while reducing the overall cost to society. Partnerships like the one with DCSI will help strengthen the overall cancer care delivery ecosystem in Delhi and ensure people have access to quality treatment options.”
Dr Kishore Singh, Director, Delhi State Cancer Institute (DSCI) added, “Cancer is emerging as a major public health concern in Delhi. The growing burden of the disease has drawn attention from various government bodies and public health institutions. This partnership is an effort by Delhi government to improve cancer care infrastructure in the state. We are hoping to help our doctors and healthcare workers to better deal with the increasing burden of Cancer and provide better care to the people.”